IKS Health in talks for TruBridge

IKS Health is in advanced talks to buy TruBridge in a take-private deal worth about $600 million, according to people cited by the Economic Times. (economictimes.indiatimes.com) The Economic Times reported on April 13 that IKS, backed by the family of late investor Rakesh Jhunjhunwala, could make a formal announcement soon if negotiations hold. Outlook Business separately reported the deal is being discussed as an all-cash offer. (economictimes.indiatimes.com) (outlookbusiness.com) TruBridge closed at $17.98 on April 10, giving the Nasdaq-listed company a market value below the reported deal figure. TruBridge serves rural and community hospitals and sells software and billing services that help providers collect payment. (investors.trubridge.com) (finance.yahoo.com) In healthcare billing, revenue cycle management means handling the steps from patient registration to insurer payment and final collection. TruBridge’s largest business is its Financial Health segment, which produced $221.7 million of 2025 revenue, or 64% of the company total. (barchart.com) (morningstar.com) The appeal for a buyer is the mix of repeat sales and improving profit. TruBridge said recurring revenue was 94% of 2025 revenue, while adjusted earnings before interest, taxes, depreciation and amortization rose to $68.7 million from $55.9 million a year earlier. (barchart.com) (finance.yahoo.com) TruBridge’s 2025 revenue was $346.8 million, up from $342.2 million in 2024, and bookings were $82.9 million. Chief executive Chris Fowler said on March 31 that margin gains came from cost management and an offshoring strategy. (barchart.com) (investors.trubridge.com) That operating profile helps explain why a strategic buyer would look past TruBridge’s modest top-line growth. A company with 94% recurring revenue gives an acquirer more visibility into renewals, pricing, and how quickly cost cuts can turn into cash flow. (investors.trubridge.com) (finance.yahoo.com) For IKS, the fit is in the United States healthcare back office. PitchBook describes IKS as a healthcare services company focused on clinical and revenue cycle management solutions, and the company’s investor relations site lists financial disclosures after its public listing in India. (pitchbook.com) (ikshealth.com) Outlook Business reported that IKS has discussed a financing package of about $675 million with Citi, Deutsche Bank and JPMorgan, with the extra amount meant to cover TruBridge debt refinancing as well as the equity purchase. Neither IKS nor TruBridge had announced a transaction on their investor relations pages as of April 13. (outlookbusiness.com) (ikshealth.com) (investors.trubridge.com) The next step is simple: either the talks produce a signed offer, or they do not. Until then, the numbers buyers will keep returning to are TruBridge’s recurring revenue, its 2025 margin expansion, and whether IKS can turn those hospital billing contracts into a larger United States platform. (economictimes.indiatimes.com) (barchart.com)